There‘s another price war brewing in the anti-cancer drug market and patients have the Indian Patent Office to thank for it, reports Archana Shukla of CNBC-TV18.
first published: Oct 8, 2012 09:57 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty extends gain to the second straight day but sees another weekly loss | Closing Bell
Live: Can Nifty extend gains and reclaim 26,000? | Opening Bell
FSS Simply Payments 2025 | AI in Payments: Building a Governance-First Future.
Live: Nifty reclaims 25,900, snaps 3-day losing streak; rupee falls to fresh low | Closing Bell
